Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2012-02-17

FDA Approved: ENALAPRIL MALEATE — Supplemental Application (OCEANSIDE PHARMACEUTICALS)

View source ↗

Summary

The FDA approved a supplemental application for enalapril maleate (Oceanside Pharmaceuticals), resulting in a labeling update for the product. The change is rel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enalapril maleate (enalapril maleate)

Snippet

SUPPL AP for ENALAPRIL MALEATE (ENALAPRIL MALEATE)